Hesperetin As an Anti-Sars-Cov-2 Agent Can Inhibit Covid-19-Associated Cancer Progression by Suppressing Intracellular Signaling Pathways

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Hesperetin As an Anti-Sars-Cov-2 Agent Can Inhibit Covid-19-Associated Cancer Progression by Suppressing Intracellular Signaling Pathways Publisher Pubmed

Zalpoor H^{1, 2} ; Bakhtiyari M^{2, 3} ; Shapourian H⁴ ; Rostampour P⁵ ; Tavakol C⁶ ; Nabiafjadi M⁷

Source: Inflammopharmacology Published:2022

Abstract

Hesperetin, an aglycone metabolite of hesperidin with high bioavailability, recently gained attention due to its anti-COVID-19 and anti-cancer properties. Multiple studies revealed that cancer patients are prone to experience a severe form of COVID-19 and higher mortality risk. In addition, studies suggested that COVID-19 can potentially lead to cancer progression through multiple mechanisms. This study proposes that hesperetin not only can be used as an anti-COVID-19 agent but also can reduce the risk of multiple cancer progression by suppressing several intracellular signaling pathways in cancer patients with COVID-19. Therefore, in this review, we attempted to provide evidence demonstrating anti-COVID-19/cancer properties of hesperetin with several mechanisms. © 2022, The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Related Docs

View other Related Docs

1. Kaempferol's Potential Effects Against Sars-Cov-2 and Covid-19-Associated Cancer Progression and Chemo-Resistance, Phytotherapy Research (2023)

2. Flt3-Itd Mutated Acute Myeloid Leukemia Patients and Covid-19: Potential Roles of Autophagy and Hif-1Α in Leukemia Progression and Mortality, Human Cell (2022)

3. The Role of Natural Products As Inhibitors of Jak/Stat Signaling Pathways in Glioblastoma Treatment, Oxidative Medicine and Cellular Longevity (2022)

Experts (# of related papers)

View all Related Experts

Mazdak Ganjalikhani Hakemi (3)

Mohammad Bagherniya (1)

Other Related Docs

4. A Narrative Review on the Role of Hesperidin on Metabolic Parameters, Liver Enzymes, and Inflammatory Markers in Nonalcoholic Fatty Liver Disease, Food Science and Nutrition (2023)

5. Increased Neuropilin-1 Expression by Covid-19: A Possible Cause of Long-Term Neurological Complications and Progression of Primary Brain Tumors, Human Cell (2022)

6. The Favorable Impacts of Silibinin Polyphenols As Adjunctive Therapy in Reducing the Complications of Covid-19: A Review of Research Evidence and Underlying Mechanisms, Biomedicine and Pharmacotherapy (2022)

7. Potential Role of Autophagy Induced by Flt3-Itd and Acid Ceramidase in Acute Myeloid Leukemia Chemo-Resistance: New Insights, Cell Communication and Signaling (2022)

8. Quercetin Potential Effects Against Sars-Cov-2 Infection and Covid-19-Associated Cancer Progression by Inhibiting Mtor and Hypoxia-Inducible Factor-1Α (Hif-1Α), Phytotherapy Research (2022)

9. A Review of Plant Extracts and Plant-Derived Natural Compounds in the Prevention/Treatment of Neonatal Hypoxic-Ischemic Brain Injury, International Journal of Molecular Sciences (2021)

10. Herbal Medicines As Potential Inhibitors of Sars-Cov-2 Infection, Current Pharmaceutical Design (2022)

11. Effect of Polyphenols Against Complications of Covid-19: Current Evidence and Potential Efficacy, Pharmacological Reports (2024)

Style	Citing Format
MLA	Zalpoor H, et al.. "Hesperetin As an Anti-Sars-Cov-2 Agent Can Inhibit Covid-19-Associated Cancer Progression by Suppressing Intracellular Signaling Pathways." Inflammopharmacology, vol. 30, no. 5, 2022, pp. 1533-1539.
APA	Zalpoor H, Bakhtiyari M, Shapourian H, Rostampour P, Tavakol C, Nabiafjadi M (2022). Hesperetin As an Anti-Sars-Cov-2 Agent Can Inhibit Covid-19-Associated Cancer Progression by Suppressing Intracellular Signaling Pathways. Inflammopharmacology, 30(5), 1533-1539.
Chicago	Zalpoor H, Bakhtiyari M, Shapourian H, Rostampour P, Tavakol C, Nabiafjadi M. "Hesperetin As an Anti-Sars-Cov-2 Agent Can Inhibit Covid-19-Associated Cancer Progression by Suppressing Intracellular Signaling Pathways." Inflammopharmacology 30, no. 5 (2022): 1533-1539.
Harvard	Zalpoor H et al. (2022) 'Hesperetin As an Anti-Sars-Cov-2 Agent Can Inhibit Covid-19-Associated Cancer Progression by Suppressing Intracellular Signaling Pathways', Inflammopharmacology, 30(5), pp. 1533-1539.
Vancouver	Zalpoor H, Bakhtiyari M, Shapourian H, Rostampour P, Tavakol C, Nabiafjadi M. Hesperetin As an Anti-Sars-Cov-2 Agent Can Inhibit Covid-19-Associated Cancer Progression by Suppressing Intracellular Signaling Pathways. Inflammopharmacology. 2022;30(5):1533-1539.
BibTex	@article{ author = {Zalpoor H and Bakhtiyari M and Shapourian H and Rostampour P and Tavakol C and Nabiafjadi M}, title = {Hesperetin As an Anti-Sars-Cov-2 Agent Can Inhibit Covid-19-Associated Cancer Progression by Suppressing Intracellular Signaling Pathways}, journal = {Inflammopharmacology}, volume = {30}, number = {5}, pages = {1533-1539}, year = {2022} }
RIS	TY - JOUR AU - Zalpoor H AU - Bakhtiyari M AU - Shapourian H AU - Rostampour P AU - Tavakol C AU - Nabiafjadi M TI - Hesperetin As an Anti-Sars-Cov-2 Agent Can Inhibit Covid-19-Associated Cancer Progression by Suppressing Intracellular Signaling Pathways JO - Inflammopharmacology VL - 30 IS - 5 SP - 1533 EP - 1539 PY - 2022 ER -

Science Communicator Platform

Authors

Abstract